{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:45:00Z","timestamp":1790804700697,"version":"4.1.0"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T00:00:00Z","timestamp":1442188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0137022","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T18:44:43Z","timestamp":1442256283000},"page":"e0137022","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Quinolinic Acid Responses during Interferon-\u03b1-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory Hypothesis"],"prefix":"10.1371","volume":"10","author":[{"given":"Andreas","family":"Baranyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Meinitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Breitenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Amouzadeh-Ghadikolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Stauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Bernd","family":"Rothenh\u00e4usler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1176\/appi.ajp.160.7.1342","article-title":"Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy","volume":"160","author":"L Capuron","year":"2003","journal-title":"Am J Psychiatry"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-0327(02)00264-1","article-title":"Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus","volume":"72","author":"S Bonaccorso","year":"2002","journal-title":"J Affect Disord"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","article-title":"Increased depressive ratings in patients with hepatitis C receiving interferon-\u03b1 based immunotherapy are related to interferon-\u03b1 induced changes in the serotonergic system","volume":"22","author":"S Bonaccorso","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1176\/appi.ajp.160.1.172","article-title":"Prevalence of hepatitis C among psychiatric patients in the public sector","volume":"160","author":"SH Dinwiddie","year":"2003","journal-title":"Am J Psychiatry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000348587","article-title":"A biopsychosocial model of interferon-alpha-induced depression in patients with chronic hepatitis C infection","volume":"82","author":"A Baranyi","year":"2013","journal-title":"Psychother Psychosom"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0091-3057(94)90294-1","article-title":"Reversible cognitive decline during high-dose alpha-interferon treatment","volume":"47","author":"E. Poutiainen","year":"1994","journal-title":"Pharmacol Biochem. Behav"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2012.07.037","article-title":"Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement","volume":"57","author":"M Schaefer","year":"2012","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1053\/jhep.2002.32672","article-title":"Mechanism of action of ribavirin in the combination treatment of chronic HCV infection","volume":"35","author":"JY Lau","year":"2002","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.euroneuro.2012.03.009","article-title":"Pre-treatment waking cortisol response and vulnerability to interferon \u03b1 induced depression","volume":"22","author":"J Eccles","year":"2012","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.23699","article-title":"Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C","volume":"52","author":"PD Leutscher","year":"2010","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/01.psy.0000145824.82125.a8","article-title":"Biopsychosocial predictors of health-related quality of life in patients with chronic hepatitis C","volume":"66","author":"W Hauser","year":"2004","journal-title":"Psychosom Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.12r07694","article-title":"Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis","volume":"73","author":"M Udina","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.PSY.0000078188.74020.CC","article-title":"Tryptophan as a link between psychopathology and somatic states","volume":"65","author":"S Russo","year":"2003","journal-title":"Psychosom Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/107999001300177457","article-title":"Neuropsychiatric effects and type of IFN-alpha in chronic hepatitis C","volume":"21","author":"M Malaguarnera","year":"2001","journal-title":"J Interferon Cytokine Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1176\/ajp.156.7.1120","article-title":"Depression from interferon therapy in patients with hepatitis C","volume":"156","author":"H Miyaoka","year":"1999","journal-title":"Am J Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1176\/appi.ajp.157.6.867","article-title":"Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review","volume":"157","author":"E Dieperink","year":"2000","journal-title":"Am J Psychiatry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1572-0241.2001.03473.x","article-title":"Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C","volume":"96","author":"RJ Fontana","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v66n0106","article-title":"Depression during pegylated interferon alpha plus ribavirin therapy: Prevalence and prediction","volume":"66","author":"CL Raison","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ajp.162.4.805","article-title":"Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects","volume":"162","author":"A Neumeister","year":"2005","journal-title":"Am J Psychiatry"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.mehy.2005.01.026","article-title":"5-Hydroxytryptophan plus SSRI for interferon-induced depression: Synergistic mechanisms for normalizing synaptic serotonin","volume":"65","author":"EH Turner","year":"2005","journal-title":"Medical Hypotheses"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1017\/S1461145702003103","article-title":"The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans","volume":"5","author":"M Wichers","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref22","first-page":"11","article-title":"The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression","volume":"19","author":"MC Wichers","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.mp.4001600","article-title":"IDO and interferon-alpha-induced depressive symptoms: A shift in hypothesis from tryptophan depletion to neurotoxicity","volume":"10","author":"MC Wichers","year":"2005","journal-title":"Mol Psychiatry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-2-16","article-title":"Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex","volume":"2","author":"GJ Guillemin","year":"2005","journal-title":"J Neuroinflammation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.cca.2014.06.010","article-title":"Development of a liquid chromatography-mass spectrometry method for the determination of the neurotoxic quinolinic acid in human serum","volume":"436C","author":"A Meinitzer","year":"2014","journal-title":"Clin Chim Acta"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0378-4347(95)00341-X","article-title":"Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorometric detection","volume":"675","author":"C Herv\u00e9","year":"1996","journal-title":"J Chromatogr B Biomed Appl"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cca.2008.05.004","article-title":"Simultaneous determination of kynurenin and kynurenic acid concentrations in human serum by HPLC with dual wavelengths","volume":"395","author":"LD Xiao","year":"2008","journal-title":"Clin Chim Acta"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jchromb.2012.04.030","article-title":"Development and validation of a single analytical method for the determination. of tryptophan, and its kynurenine metabolites in rat plasma","volume":"898","author":"M M\u00f6ller","year":"2012","journal-title":"J Chromat B"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","article-title":"Development of a rating scale for primary depressive illness","volume":"6","author":"M Hamilton","year":"1967","journal-title":"Br J Soc Clin Psychol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-8-94","article-title":"Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?","volume":"8","author":"J Steiner","year":"2011","journal-title":"J Neuroinflammation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/15622975.2011.583941","article-title":"Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity","volume":"13","author":"J. Steiner","year":"2012","journal-title":"World J Biol Psychiatry"},{"key":"ref32","article-title":"Cerebral cortex, hippocampus, striatum and cerebellum show differential susceptibility to quinolinic acid-induced oxidative stress","author":"S Vandresen-Filho","year":"2015","journal-title":"Neurol Sci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0197-0186(95)00091-7","article-title":"The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits","volume":"28","author":"L Prado de Carvalho","year":"1996","journal-title":"Neuroche Int"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-3565(25)21648-2","article-title":"Pharmacology and regional variations of quinolinic acid-evoked excitations in the rat central nervous system","volume":"226","author":"MN Perkins","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0304-3940(83)90115-5","article-title":"Differential vulnerability of central neurons of the rat to quinolinic acid","volume":"38","author":"R Schwarcz","year":"1983","journal-title":"Neurosci Lett"},{"key":"ref36","article-title":"Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?","author":"M Busse","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0197-0186(01)00133-4","article-title":"Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes","volume":"40","author":"RG Tavares","year":"2002","journal-title":"Neurochem Int"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00702-009-0299-5","article-title":"Antioxidant strategy to rescue synaptosomes from oxidative damage and energy failure in neurotoxic models in rats: protective role of S-allylcysteine","volume":"117","author":"D Elinos-Calder\u00f3n","year":"2010","journal-title":"J Neural Transm"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1038\/sj.bjp.0702940","article-title":"Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl","volume":"128","author":"WM Behan","year":"1999","journal-title":"Br J Pharmacol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/sj.bjp.0704613","article-title":"Enhanced neuronal damage by co-administration of quinolinic acid and free radicals, and protection by adenosine A2A receptor antagonists","volume":"135","author":"WM Behan","year":"2002","journal-title":"Br J Pharmacol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1742-4658.2009.07487.x","article-title":"Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons","volume":"277","author":"N Braidy","year":"2010","journal-title":"FEBS J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/00001756-200103260-00049","article-title":"Quinolinic acid induces oxidative stress in rat brain synaptosomes","volume":"12","author":"A Santamar\u00eda","year":"2001","journal-title":"Neuroreport"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1097\/00001756-200108280-00020","article-title":"In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum","volume":"12","author":"A Santamar\u00eda","year":"2001","journal-title":"Neuroreport"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0006-8993(93)90615-T","article-title":"Quinolinate potentiates the neurotoxicity of excitatory amino acids in hypoxic neuronal tissue in vitro","volume":"617","author":"A Schurr","year":"1993","journal-title":"Brain Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"79","author":"GJ Guillemin","year":"2012","journal-title":"FEBS J."},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.06.024","article-title":"Acute intrastriatal injection of quinolinic acid provokes long-lasting misregulation of the cytoskeleton in the striatum, cerebral cortex and hippocampus of young rats","volume":"1577","author":"P Pierozan","year":"2014","journal-title":"Brain Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.expneurol.2010.03.009","article-title":"Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats","volume":"224","author":"P Pierozan","year":"2010","journal-title":"Exp Neurol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e6344","DOI":"10.1371\/journal.pone.0006344","article-title":"The excitotoxin quinolinic acid induces tau phosphorylation in human neurons","volume":"4","author":"A Rahman","year":"2009","journal-title":"PLoS One"},{"key":"ref49","article-title":"Quinolinic acid toxicity on oligodendroglial cells: relevance for multiple sclerosis and therapeutic strategies","author":"G Sundaram","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"e14123","DOI":"10.1371\/journal.pone.0014123","article-title":"Characterisation of the expression of NMDA receptors in human astrocytes","volume":"5","author":"MC Lee","year":"2010","journal-title":"PLoS One"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","article-title":"Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons","volume":"16","author":"N Braidy","year":"2009","journal-title":"Neurotox Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11011-008-9114-5","article-title":"Neuropsychiatric disorders related to interferon and interleukins treatment","volume":"24","author":"AM Myint","year":"2009","journal-title":"Metab Brain Dis"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"e0130715","DOI":"10.1371\/journal.pone.0130715","article-title":"Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis","volume":"10","author":"R Mancuso","year":"2015","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0137022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T16:43:40Z","timestamp":1748623420000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0137022"}},"subtitle":[],"editor":[{"given":"Gilles J.","family":"Guillemin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,14]]},"references-count":53,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0137022","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,14]]}}}